Qianshan Hou

Risk stratification based on DNA damage-repair-related signature reflects the microenvironmental feature, metabolic status and therapeutic response of breast cancer

Jie Chen, Shuangni Yu, Shulei Yin, 2023, Frontiers in Immunology.

Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer

Chunzhen Li, Qianshan Hou, Lanjie Yang, 2024, Frontiers in immunology.